Washington University in St. Louis (WU)
Currently, my clinical interests are in hematology/oncology practice, specifically in lymphoma, cellular therapy and hematopoietic stem cell transplantation. My long-term research interests include understating key cell signaling pathways that lead to the immunomodulatory effects of highly selective HDAC6 inhibitors. I am particularly interested in the effects of HDAC6 inhibition as it pertains to lymphoma immunotherapies and the tumor microenvironment including macrophage phenotype polarization.